The latest findings on the comparison of medication versus percutaneous coronary intervention (PCI), the term currently used for angioplasty and stenting, for stable coronary artery disease -- this time assessing quality of life -- have shown that while both groups' health status and quality of life improved, PCI had a slight advantage over medical treatment alone during the first two years.